Multiple myeloma highlights and more from ASH 2018

Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia

An integrated view of the role of the B cell antigen receptor in lymphoma cell fitness

Myeloma XI study: Quadruplet regimen for transplant eligible patients

Developments in CAR T treatments for adult patients

Outcomes for patients with disease progression following CD19-specific CAR T-cell therapy

ASH 2018: Expert overview of the latest in CLL, ALL and AML

Updates on the ELIANA trial for acute lymphocytic leukaemia in young patients

Determining the prognosis of patients with myelodysplastic syndromes using machine learning

Long term data from JULIET trial, using tisagenlecleucel for patients with relapsed or treatment-resistant DLBCL

ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma

Link between gut microbiota and haematopoietic cell transplantation outcomes